According to FutureWise analysis the market for Pharmaceutical Excipients is expected to reach US$ 13.91 billion by 2031 at a CAGR of 6.80%.
A pharmaceutical excipient acts as a synthetic or natural substance made with an active ingredient of a medication. It is found in the form of a pharmaceutical dosage to help in the manufacturing operations and it serves to support, protect or even heighten stability. Additionally, they aid in identifying the products and strengthen the safety or functional aspects of the product.
The surge in the pharmaceutical excipients market potential can be the result of the expanding pharmaceuticals industry along with innovations in functional excipients, the growing acceptance of orphan drugs, and the rise in the allowance of biopharmaceuticals. However, the high costs, time consumption in the drug development procedure, as well as the stringency enacted by regulatory bodies are factors which may pose hindrances to the market growth during the forecast time frame.
By product type, the market for pharmaceutical excipients is classified into three primary categories namely, inorganic chemicals, organic chemicals as well as other chemicals. The organic chemicals was demonstrated to hold the largest market share. The considerable market share is owing to the usage of these chemicals in the numerous pharmaceutical formulations which are accessible in the pharmaceutical market.
The diluents fillers segment has acquired a bulk of the market share of the pharmaceutical excipients industry. The significant market value of this segment is linked to the growing usage of diluents fillers in the production and development processes of solid oral drugs and the benefits that they provide to patients and manufacturers alike.
With the formulation, the pharmaceutical excipients market is divided into topical, oral, parenteral, as well as formulations. Oral formulations has seen robust growth for this market, primarily due to oral formulations being the most common method of drug delivery.